The targeting construct is designed to insert a creERT2 fusion gene (a Cre recombinase fused to a human estrogen receptor ligand binding domain) followed by an SV40 polyadenylation signal, and a FRT-flanked neomycin resistance (neo) cassette into exon 2 of the gene. Flp-mediated recombination removed the FRT-flanked neo cassette. (J:256199)
Basic Information
(129S6/SvEvTac x C57BL/6NCrl)F1
Legend:
cx: complex: > 1 genome feature ot: other: hemizygous, indeterminate,... (F): Female
(M): Male
N: normal phenotype
(#): related diseases count